Abiopharma

New Form EFFECT - Cabaletta Bio, Inc. Filed: 2025-08-15 AccNo: 9999999995-25-002642 Size: 1 KB

New Form EFFECT - Biomea Fusion, Inc. Filed: 2025-08-15 AccNo: 9999999995-25-002637 Size: 1 KB

New Form EFFECT - STREAMLINE HEALTH SOLUTIONS INC. Filed: 2025-08-15 AccNo: 9999999995-25-002630 Size: 2 KB

New Form EFFECT - STREAMLINE HEALTH SOLUTIONS INC. Filed: 2025-08-15 AccNo: 9999999995-25-002628 Size: 2 KB

New Form EFFECT - STREAMLINE HEALTH SOLUTIONS INC. Filed: 2025-08-15 AccNo: 9999999995-25-002629 Size: 2 KB

New Form EFFECT - Lyell Immunopharma, Inc. Filed: 2025-08-15 AccNo: 9999999995-25-002652 Size: 1 KB

New Form EFFECT - STREAMLINE HEALTH SOLUTIONS INC. Filed: 2025-08-15 AccNo: 9999999995-25-002633 Size: 2 KB

New Form EFFECT - STREAMLINE HEALTH SOLUTIONS INC. Filed: 2025-08-15 AccNo: 9999999995-25-002631 Size: 2 KB

New Form EFFECT - STREAMLINE HEALTH SOLUTIONS INC. Filed: 2025-08-15 AccNo: 9999999995-25-002634 Size: 2 KB

New Form EFFECT - STREAMLINE HEALTH SOLUTIONS INC. Filed: 2025-08-15 AccNo: 9999999995-25-002632 Size: 2 KB

Other Scheme of Arrangement: COURT SANCTION OF SCHEME

IDEAYA Biosciences Announces Agenda for 10-Year Anniversary R&D Day on September 8, 2025

Westlake - Westlake Corporation Advances Sustainability Goals Toward 2030 Carbon-Reduction Target

Natera - IMvigor011 Bladder Cancer Trial Achieves Positive Results, with Signatera™ Strongly Predicting Adjuvant Immunotherapy Benefit

General Announcement: CBH RAISED S$1.98 MILLION FROM PLACEMENT; BACKED BY HIGH-PROFILE INVESTORS TO FUEL STRATEGIC GROWTH